Emily Hill

Dr. Emily Hill serves as Associate Professor in the Division of Gynecologic Oncology within the Department of Obstetrics and Gynecology at the Medical College of Wisconsin, joining in September 2025 after a decade of practice at the University of Iowa. Board certified in both Obstetrics & Gynecology (2013) and Gynecologic Oncology (2019), her clinical expertise spans surgical and medical management of uterine, ovarian, cervical, vulvar, and vaginal malignancies including gestational trophoblastic disease.

Her educational background includes:

• Doctor of Medicine – University of Wisconsin School of Medicine and Public Health (2007)
• Residency in Obstetrics & Gynecology – University of Chicago (2007-2011)
• Gynecologic Oncology Fellowship – Brown University/Women & Infants Hospital (2011-2015)

Dr. Hill's research emphasizes hereditary genetic mutations across breast-ovarian and endometrial cancer syndromes, gynecologic quality improvement initiatives, and HPV vaccination strategies. She actively advocates for clinical trial participation and has presented findings at national conferences including The Society of Gynecologic Oncology.

Analysis of her recent publications reveals dominant themes in endometrial cancer immunotherapy (particularly pembrolizumab combinations), surgical innovation for vulvar cancer staging, and management of treatment complications like ureteral obstruction. Her work increasingly integrates quality-of-life metrics with clinical outcomes through home-based interventions and navigation support programs.

Recognized with multiple teaching awards throughout her training and faculty career, Dr. Hill maintains active membership in The Society of Gynecologic Oncology. Her clinical practice at Courage Clinic – Froedtert Clinical Cancer Center serves adolescent through senior patients using minimally invasive surgical techniques and targeted chemotherapy regimens.